MAR logo Marriott International +
Marriott International
+

Marriott International (MAR) Business News

Track Marriott International in real time with a live news feed covering Marriott International stock news, official press releases, company announcements, and an archive of historical Marriott International news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
4:00 PM | Monday | Jul 13, 2026 PRNewsWire

Marriott International Announces Release Date For Second Quarter 2026 Earnings

News Thumbnail
11:00 AM | Wednesday | Jul 1, 2026 PRNewsWire

Beyond The Gen Z Myth: Four Distinct Luxury Mindsets Reshaping Travel in Asia Pacific

News Thumbnail
7:00 AM | Wednesday | Jul 1, 2026 PRNewsWire

An Iconic Pairing: Marriott International and The Coca‑Cola Company Come Together in Strategic Beverage Agreement

News Thumbnail
8:51 AM | Monday | Jun 22, 2026 GlobeNewsWire

Novo Nordisk A/S - share repurchase programme

News Thumbnail
12:00 PM | Wednesday | Jun 17, 2026 PRNewsWire

Design Hotels Announces Addition of Multi-Property Portfolio with Renowned Independent Hospitality Brand, Palisociety

News Thumbnail
9:00 AM | Tuesday | Jun 16, 2026 PRNewsWire

Marriott International Introduces Ask Bonvoy™ a New AI-Powered Search Experience Transforming Travel Exploration

News Thumbnail
8:00 AM | Monday | Jun 15, 2026 Business Wire

Marea Therapeutics Presents Phase 1 Data Supporting Potential Best-in-Disease Profile of MAR002 for the Treatment of Acromegaly at ENDO 2026

News Thumbnail
6:00 AM | Thursday | Jun 11, 2026 PRNewsWire

Marriott International Celebrates 10,000 Properties Globally with the Opening of the JW Marriott Ranthambore Resort & Spa

News Thumbnail
10:00 AM | Wednesday | Jun 10, 2026 PRNewsWire

Marriott International Completes Transaction to Bring Lefay into its Global Portfolio through Joint Venture

News Thumbnail
8:55 AM | Thursday | May 28, 2026 Business Wire

Peachtree Group Celebrates Grand Opening of TownePlace Suites by Marriott Palmdale

News Thumbnail
4:00 PM | Tuesday | May 26, 2026 Business Wire

Marea Therapeutics to Present Data from Phase 1 Study of MAR002 for the Treatment of Acromegaly at ENDO 2026

News Thumbnail

Marriott International Announces Release Date For Second Quarter 2026 Earnings

PRNewsWire

4:00 PM | Monday | Jul 13, 2026

news photo
Loading...

BETHESDA, Md., July 13, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) will report second quarter 2026 earnings results on Monday, August 3, 2026, at approximately 7:00 a.m.

Read full article redirect
4:00 PM | Monday | Jul 13, 2026

Marriott International Announces Release Date For Second Quarter 2026 Earnings

PRNewsWire

BETHESDA, Md., July 13, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) will report second quarter 2026 earnings results on Monday, August 3, 2026, at approximately 7:00 a.m.

Read full article arrow
News Thumbnail
11:00 AM | Wednesday | Jul 1, 2026

Beyond The Gen Z Myth: Four Distinct Luxury Mindsets Reshaping Travel in Asia Pacific

PRNewsWire

New research by the Luxury Group by Marriott International challenges assumptions about Gen Z travelers, uncovering diverse motivations and definitions of luxury travel. SINGAPORE, July 1, 2026 /PRNewswire/ -- As Gen Z rises as a defining force in luxury travel, one long-held assumption no longer holds: there is no single Gen Z traveler.

Read full article arrow
News Thumbnail
7:00 AM | Wednesday | Jul 1, 2026

An Iconic Pairing: Marriott International and The Coca‑Cola Company Come Together in Strategic Beverage Agreement

PRNewsWire

BETHESDA, Md. and ATLANTA, July 1, 2026 /PRNewswire/ -- Marriott International, Inc. (NASDAQ: MAR) and The Coca‑Cola Company (NYSE: KO) today announced a global agreement that will expand choice and elevate the guest experience across Marriott's portfolio, bringing The Coca‑Cola Company's brands to hotels around the world.

Read full article arrow
News Thumbnail
8:51 AM | Monday | Jun 22, 2026

Novo Nordisk A/S - share repurchase programme

GlobeNewsWire

Bagsværd, Denmark, 22 June 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.

Read full article arrow
News Thumbnail
12:00 PM | Wednesday | Jun 17, 2026

Design Hotels Announces Addition of Multi-Property Portfolio with Renowned Independent Hospitality Brand, Palisociety

PRNewsWire

Two pioneers of design-led hospitality with a shared commitment to individuality come together in Design Hotels' largest single portfolio addition to date. BERLIN, June 17, 2026 /PRNewswire/ -- Design Hotels today announced a landmark portfolio expansion with Palisociety, the Los Angeles-based independent hospitality brand known for its design-forward hotels in key U.S. markets.

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Jun 16, 2026

Marriott International Introduces Ask Bonvoy™ a New AI-Powered Search Experience Transforming Travel Exploration

PRNewsWire

Marriott International launches Ask Bonvoy, a new conversational, natural language search experience designed to help Marriott Bonvoy members more intuitively explore the Marriott Bonvoy portfolio of approximately 10,000 properties in 146 countries and territories. Ask Bonvoy is launching in beta and will initially be available in U.S. English on Marriott.com and in the iOS and Android Marriott Bonvoy mobile apps to a subset of Marriott Bonvoy members and users who sign up for Marriott Bonvoy.

Read full article arrow
News Thumbnail
8:00 AM | Monday | Jun 15, 2026

Marea Therapeutics Presents Phase 1 Data Supporting Potential Best-in-Disease Profile of MAR002 for the Treatment of Acromegaly at ENDO 2026

Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today highlighted the presentation of data from its first-in-human Phase 1 study of MAR002 at the 2026 Annual Meeting of the Endocrine Society (ENDO). MAR002 is a first-in-class allosteric monoclonal antibody targeting the growth hormone receptor (GHR). Da.

Read full article arrow
News Thumbnail
6:00 AM | Thursday | Jun 11, 2026

Marriott International Celebrates 10,000 Properties Globally with the Opening of the JW Marriott Ranthambore Resort & Spa

PRNewsWire

Key Facts Marriott International opened its 10,000th property globally, the JW Marriott Ranthambore Resort & Spa in India, marking a historic milestone as the company approaches its 100th anniversary. The JW Marriott Ranthambore Resort & Spa features 127 accommodations, including private villas, and is located near Ranthambore National Park.

Read full article arrow
News Thumbnail
10:00 AM | Wednesday | Jun 10, 2026

Marriott International Completes Transaction to Bring Lefay into its Global Portfolio through Joint Venture

PRNewsWire

BETHESDA, Md., June 10, 2026 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) today announced it has entered into a joint venture with the Leali family, founders of Lefay, to bring the highly regarded luxury wellness hospitality brand into Marriott's global portfolio.

Read full article arrow
News Thumbnail
8:55 AM | Thursday | May 28, 2026

Peachtree Group Celebrates Grand Opening of TownePlace Suites by Marriott Palmdale

Business Wire

ATLANTA--(BUSINESS WIRE)--Peachtree Group announced the grand opening of the TownePlace Suites by Marriott Palmdale in California.

Read full article arrow
News Thumbnail
4:00 PM | Tuesday | May 26, 2026

Marea Therapeutics to Present Data from Phase 1 Study of MAR002 for the Treatment of Acromegaly at ENDO 2026

Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that data from its first-in-human Phase 1 study of MAR002 will be highlighted in an oral presentation at the 2026 Annual Meeting of the Endocrine Society (ENDO), being held from June 13-16 in Chicago, IL. MAR002 is a first-in-class alloster.

Read full article arrow
News Thumbnail